The ongoing seminar series promotes clinical and translational research while fostering creativity, innovation and dissemination. Our audience consists of faculty, trainees, medical students and research staff.
This event will be held over zoom. Start time and zoom link TBA.
The Weill Cornell CTSC with Office of Faculty Development is pleased to host two mentoring experts for an engaging program on how to use an Individual Development Plan (IDP), and strategies to seek and build research mentoring relationships.
Fellows, residents, students and faculty members are encouraged to participate; those from all training levels are welcome. Sign up for a full day or individual sessions.
The Translational Science (TS) Program Committee is seeking one predoctoral student and one postdoctoral fellow who are currently in a TL1 training program funded by the National Center for Advancing Translational Sciences (NCATS) to serve on the TS Program Committee.
The TS Program Committee is responsible for the program content of the annual meeting of the Association for Clinical and Translational Science (ACTS). This is a great opportunity to take an active role in programming the science and format of the annual meeting.
The Meyer Cancer Center Solid Tumors Research Program presents:
Barry Sleckman, M.D., Ph.D.
Professor of Pathology and Laboratory Medicine
Weill Cornell Medicine
Xiaochun Cai, Ph.D.
Lab of Dr Minkui Luo
Postdoctoral Associate
Memorial Sloan-Kettering Cancer Center
Department of Molecular Pharmacology & Chemistry
Department of Pharmacology
Fall/Winter 2017-2018 Seminar Series
Marta Melis, Ph.D.
Lab of Dr. Lorraine J. Gudas
Postdoctoral Associate
Weill Cornell Medical College
Department of Pharmacology
"Translational Pharmacogenomics: Discovery, Education, and Implementation"
Stuart A. Scott, Ph.D., FACMG
Division Head, Pharmacogenomics
Director, Cytogenetics and Cytogenomics
Associate Professor
Department of Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
“Characterizing and targeting the breast tumor immune microenvironment”
Ashley Cimino-Mathews, M.D.
Associate Professor of Pathology and Oncology
The Johns Hopkins Hospital
MSK-IMPACT: Tumor and normal sequencing to guide diagnosis, treatment selection, and clinical trial enrollment
Speaker: Michael F. Berger, PhD
Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center
"Tumor Microenvironment Immune Infiltration & Clinical Utility of Targeted Sequencing for Pediatric Brain Tumors"
Speaker: Prajwal Rajappa, MD
Pediatric Brain Tumor Precision Medicine Fellow
Weill Cornell Brain and Spine Center
CME credit to attendees. Lunch will be provided
